The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
12
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure.EBI
University of Minnesota
38
Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.EBI
Brandeis University
23
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.EBI
Brandeis University
7
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.EBI
Pharmasset
2
Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.EBI
Codon Pharmaceuticals
5
Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors.EBI
University of Camerino
20
Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.EBI
University of Minnesota
7
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.EBI
Hokkaido University
4
Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis.EBI
University of Minnesota
6
Mycophenolic acid analogs with a modified metabolic profile.EBI
University of Minnesota
13
Bis(sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase.EBI
University of Minnesota
7
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.EBI
University of Minnesota
1
Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor.EBI
University of Minnesota
2
Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.EBI
University of Minnesota
23
Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.EBI
Gilead Sciences
13
Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3.EBI
Bristol Myers Squibb
31
Novel inhibitors of IMPDH: a highly potent and selective quinolone-based series.EBI
Bristol Myers Squibb
39
Novel amide-based inhibitors of inosine 5'-monophosphate dehydrogenase.EBI
Bristol Myers Squibb
12
Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid.EBI
Syntex Research
64
Bile acid analogs as FXR/TGR5 agonists and methods of use thereofBDB
Enanta Pharmaceuticals
21
Synthesis and anticancer activity of new pyrrolocarbazoles and pyrrolo-beta-carbolines.BDB
Cnrs